| Literature DB >> 31088514 |
Marie Raynal1, Fehd Bouderraoui2, Remy Ouichka3, Julian Melchior3, Olivier Morel2, Alain Blum4, Isabelle Chary-Valckenaere3, Willy Ngueyon Sime5, Véronique Roch2, Walter Maksymowych6, Robert G Lambert7, Pierre Olivier2, Damien Loeuille3.
Abstract
PURPOSE: To assess increased sacroiliac joint (SIJ) uptake on 18F-NaF PET/CT and to compare with MRI for inflammation and with CT scan for structural damages in a population of 23 patients with spondyloarthritis (SpA).Entities:
Keywords: Inflammation; Positron emission tomography; Sacroiliitis; Spondyloarthritis
Mesh:
Substances:
Year: 2019 PMID: 31088514 PMCID: PMC6515602 DOI: 10.1186/s13075-019-1903-1
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Fig. 1Methodology of the semi-quantitative evaluation of the SIJ using for quadrants, based on the SPARCC MRI SIJ inflammation score on the cartilaginous part of the SIJ (a). Application on PET/CT (b), CT scan (c), and MRI (d)
Characteristics of the population
| Median | Mean [SD] | ||
|---|---|---|---|
| Clinical characteristics | |||
| Sex: male | 10 (43.5) | ||
| Age (years) | 44.2 [± 9.78] | ||
| Symptom duration (years) | 7.7 [± 8.5] | ||
| Axial involvement | 12(52.2) | ||
| Tobacco use | 16 (70) | ||
| Treatment | |||
| NSAIDs | 18 (78.3%) | ||
| TNF blockers* | 4 (17.4%) | ||
| Biological results | |||
| Sedimentation rate (mm at the first hour) | 14 | 23.3 [± 22.6] | |
| CRP (mg/mL) | 8 | 14.4 [± 20.6] | |
| ASAS criteria | |||
| HLA-B27 | 7 (30.4) | ||
| Arthritis | 9 (39.1) | ||
| Enthesitis | 8 (38.8) | ||
| Uveitis | 2 (8.7) | ||
| Dactylitis | 2 (8.7) | ||
| Psoriasis | 6 (26.1) | ||
| Inflammatory bowel disease | 3 (13.0) | ||
| Familial history | 4 (17.4) | ||
| Inflammatory back pain | 22 (95.7) | ||
| Good response to NSAIDs | 11 (47.8) | ||
| Biological inflammation (CRP > 5 mg/L) | 12 (52.2) | ||
| Clinical evaluation scores** | |||
| BASFI | 61.5 | 59.3 [± 23.0] | |
| BASDAI | 5.88 | 5.45 [± 2.57] | |
| BASMI | 3 | 2.9 [± 2.0] | |
| ASDAS | 3 | 3.3 [± 0.9] | |
*Anti-TNF: stopped 3 months before the MRI
**BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Activity Functional Index, BASMI Bath Ankylosing Metrology Index, ASDAS Ankylosing Spondylitis Disease Activity Score
Main clinical and imaging results concerning the SpA population
| Patient | Age | HLA B27 | CRP (mg/L) | BASDAI | Radiographic sacroiliitis | PET positive | PET activity score | PET SUVmax SIJ/sacrum | CT scan structural sacroiliitis | CT scan score for erosions | CT scan score for ankylosis | MRI inflammatory sacroiliits (ASAS criteria) | MRI score for inflammation (SPARCC) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 52 | 0 | 2.2 | 6.61 | 0 | 1 | 4.0 | 1.13 | 0 | 0 | 0 | 0 | 0 |
| 2 | 39 | 1 | 0.5 | 5.54 | 0 | 1 | 26.3 | 2.04 | 1 | 74.0 | 25.5 | 0 | 0 |
| 3 | 46 | 0 | 1.3 | 7.88 | 0 | 0 | 0 | 1.48 | 1 | 22.5 | 3 | 0 | 0 |
| 4 | 40 | 0 | 5 | 6.69 | 0 | 1 | 17.7 | 2.61 | 0 | 0 | 0 | 1 | 16.3 |
| 5 | 43 | 0 | 8.5 | 7.06 | 0 | 1 | 17.0 | 1.24 | 0 | 0 | 0 | 0 | 0 |
| 6 | 46 | 1 | 22.6 | 8.04 | 0 | 1 | 3.5 | 1.43 | 0 | 0 | 0 | 0 | 1.7 |
| 7 | 59 | 0 | 15.6 | 2.1 | 1 | 1 | 48.0 | 2.61 | 1 | 14.0 | 0 | 1 | 35.7 |
| 8 | 43 | 1 | 35.3 | 4.8 | 0 | 1 | 16.7 | 1.51 | 1 | 0 | 77.7 | 0 | 0 |
| 9 | 41 | 1 | 21.5 | 1.8 | 1 | 1 | 18.0 | 2.33 | 1 | 28.0 | 16.3 | 1 | 17.7 |
| 10 | 30 | 0 | 2.6 | 6.18 | 0 | 0 | 0 | 1.58 | 0 | 0 | 0 | 0 | 0 |
| 11 | 35 | 0 | 9.9 | 3.79 | 1 | 1 | 28.0 | 1.99 | 1 | 10.0 | 0 | 0 | 12.3 |
| 12 | 30 | 1 | 29.9 | 1.3 | 1 | 1 | 15.3 | 1.45 | 1 | 70.7 | 0 | 1 | 9.7 |
| 13 | 34 | 0 | 1 | 6.15 | 0 | 1 | 15.0 | 1.33 | 0 | 0 | 0 | 1 | 12.7 |
| 14 | 45 | 0 | 0.6 | 6.49 | 0 | 1 | 11.3 | 1.72 | 0 | 0 | 0 | 1 | 8.0 |
| 15 | 36 | 1 | 3 | 5.96 | 1 | 1 | 21.7 | 1.63 | 1 | 51.0 | 11.5 | 1 | 9.3 |
| 16 | 51 | 1 | 3.9 | 8.48 | 0 | 1 | 7.7 | 1.79 | 0 | 0 | 0 | 0 | 0 |
| 17 | 28 | 0 | 8 | 8.73 | 0 | 1 | 3.0 | 1.33 | 0 | 0 | 0 | 0 | 3.7 |
| 18 | 66 | 0 | 93.5 | 8.2 | 1 | 1 | 14.3 | 2.18 | 1 | 26.3 | 22 | 0 | 0 |
| 19 | 55 | 0 | 9 | 6.08 | 0 | 0 | 0 | 1.28 | 0 | 0 | 0 | 0 | 0 |
| 20 | 55 | 0 | 0.2 | 9.12 | 0 | 1 | 24.0 | 1.88 | 0 | 0 | 0 | 0 | 0 |
| 21 | 50 | 0 | 1.1 | 5.94 | 0 | 1 | 6.3 | 1.39 | 0 | 0 | 0 | 1 | 16.7 |
| 22 | 51 | 0 | 30.2 | 5.13 | 0 | 1 | 36.3 | 1.66 | 0 | 0 | 0 | 1 | 12.3 |
| 23 | 42 | 0 | 26 | 5.93 | 1 | 1 | 30.7 | 2.31 | 1 | 69.7 | 0 | 1 | 49 |
BASDAI Bath Ankylosing Spondylitis Disease Activity Index, SUVmax SIJ/sacrum ratio between the SUVmax for each SIJ and the SUVmax in the center of the sacrum, SPARCC SpondyloArthritis Research Consortium of Canada
Comparison between radiographic and non-radiographic SpA
| Radiographic sacroiliitis | Positive ( | Negative ( |
|---|---|---|
| 18F-NaF PET/CT | ||
| Positive ( | 7 (100%) | 13 (81.2%) |
| PET activity score (mean) | 25.1 ± 8.9 | 11.8 ± 8.8 |
| SUVmax SIJ/S (mean) | 2.1 ± 1.1 | 1.6 ± 0.4 |
| CT scans | ||
| Structural sacroiliitis ( | 7 (100%) | 3 (19%) |
| Erosion score (mean) | 37.1 ± 22.8 | 6.0 ± 10.6 |
| Ankylosis score (mean) | 7.1 ± 8.1 | 6.6 ± 11.2 |
| MRI | ||
| Inflammatory sacroiliitis ( | 5 (71.4%) | 5 (31.3%) |
| Inflammation score (mean) | 19.1 ± 13.3 | 4.5 ± 5.5 |